Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 200 of 401 entries
View as:

Transcranial Direct Current Stimulation of the Temporal Cortex in Survivors of Childhood Acute Lymphoblastic Leukemia (ALL)

Phase: N/A Priority: Normal
NCT ID: NCT04105530 Org: User:
Start: 11/18/19 End: 09/30/24 Due: 09/30/25

Pilot Study of Expanded, Donor Natural Killer Cell Infusions for Refractory Non-B Lineage Hematologic Malignancies and Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00640796 Org: User:
Start: 09/30/08 End: 04/30/14 Due: 04/30/15

A New Reagent Assay Examining Natural Parvovirus B19 Infection in Sickle Cell Disease

Phase: N/A Priority: Normal
NCT ID: NCT02261480 Org: User:
Start: 10/31/14 End: 08/31/16 Due: 08/31/17

Analysis of T Cell and Natural Killer (NK) Cell in Relation to Viral Infections in Pediatric Stem Cell Transplant Patients and Donors

Phase: N/A Priority: Normal
NCT ID: NCT02301065 Org: User:
Start: 10/13/16 End: 02/06/17 Due: 02/06/18

Evaluate Tolerability of a Multi-envelope, Prime-boost HIV Vaccine in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT00623753 Org: User:
Start: 05/31/07 End: 01/31/08 Due: 01/31/09

NHL16: Study For Newly Diagnosed Patients With Acute Lymphoblastic Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT01451515 Org: User:
Start: 05/25/12 End: 05/31/22 Due: 05/31/23

Loc3CAR: Locoregional Delivery of B7-H3-CAR T Cells for Pediatric Patients With Primary CNS Tumors

Phase: N/A Priority: Normal
NCT ID: NCT05835687 Org: User:
Start: 04/27/23 End: 03/31/28 Due: 03/31/29

Crenolanib in Combination With Sorafenib in Patients With Refractory or Relapsed Hematologic Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT02270788 Org: User:
Start: 04/02/15 End: 10/17/16 Due: 10/17/17

An Open-Label Pilot Intervention Trial to Prevent Diabetes in Prediabetic Adult Survivors of Childhood Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04742751 Org: User:
Start: 03/02/22 End: 11/30/26 Due: 11/30/27

Feasibility and Agreement of Remote Evaluation of Resting Heart Rate and Heart Rate Variability in Survivors of Hodgkin Lymphoma Treated With Chest Radiation (PILOT STUDY-SURVIVOR)

Phase: N/A Priority: Normal
NCT ID: NCT03838627 Org: User:
Start: 02/05/19 End: 06/30/23 Due: 06/30/24

Total Therapy Study XIV for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00187005 Org: User:
Start: 07/31/98 End: 07/31/02 Due: 07/31/03

Mindfulness Interventions to Improve Health Activation, Coping, and Stress Among Childhood Cancer Survivors

Phase: N/A Priority: Normal
NCT ID: NCT06053268 Org: User:
Start: 05/23/24 End: 09/27/26 Due: 09/27/27

Exploring the Physiologic, Pharmacodynamic, and Clinical Responses of Skeletal Muscle in Patients With Spinal Muscular Atrophy Treated With SMN-Directed Therapies

Phase: N/A Priority: Normal
NCT ID: NCT06532474 Org: User:
Start: 07/31/25 End: 11/30/26 Due: 11/30/27

Study Of Cold Cap Therapy For Prevention of Hairloss in Pediatric Patients Receiving Chemotherapy For Non-Malignant Indications and Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT04764357 Org: User:
Start: 06/04/21 End: 12/31/27 Due: 12/31/28

Entrectinib as a Single Agent in Upfront Therapy for Children <3 Years of Age With NTRK1/2/3 or ROS1-FUSED CNS Tumors

Phase: N/A Priority: Normal
NCT ID: NCT06528691 Org: User:
Start: 07/31/25 End: 11/30/32 Due: 11/30/33

Panobinostat With Fludarabine and Cytarabine for Treatment of Children With Acute Myeloid Leukemia or Myelodysplastic Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT02676323 Org: User:
Start: 05/03/16 End: 04/09/18 Due: 04/09/19

A Phase II Trial of Avelumab in Patients With Recurrent or Progressive Osteosarcoma

Phase: N/A Priority: Normal
NCT ID: NCT03006848 Org: User:
Start: 02/16/17 End: 03/18/20 Due: 03/18/21

Human Papillomavirus (HPV) Vaccination Among Survivors of Childhood Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01117389 Org: User:
Start: 05/31/10 End: 11/30/12 Due: 11/30/13

Phase I Study of Bevacizumab and Sorafenib Combined With Low Dose Cyclophosphamide in Patients With Refractory Solid Tumors and Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00665990 Org: User:
Start: 11/30/07 End: 08/31/13 Due: 08/31/14

Efficacy of Tobacco Quitline for Cancer Survivors

Phase: N/A Priority: Normal
NCT ID: NCT00827866 Org: User:
Start: 10/31/08 End: 11/30/13 Due: 11/30/14

A Prospective Trial of Dalbavancin-Based Prophylaxis in Children and Adolescents With High-Risk Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT06810583 Org: User:
Start: 06/30/25 End: 09/30/30 Due: 09/30/31

Therapeutic Interventions For Pain Induced By Vincristine Treatment For Childhood Acute Lymphoblastic Leukemia (ALL)

Phase: N/A Priority: Normal
NCT ID: NCT01506453 Org: User:
Start: 01/24/12 End: 01/02/18 Due: 01/02/19

Cognitive Training in the Virtual Reality Setting With Children Undergoing Radiotherapy for Brain Tumors

Phase: N/A Priority: Normal
NCT ID: NCT05947045 Org: User:
Start: 06/22/23 End: 03/31/27 Due: 03/31/28

A Clinical and Molecular Risk-Directed Therapy for Newly Diagnosed Medulloblastoma

Phase: N/A Priority: Normal
NCT ID: NCT01878617 Org: User:
Start: 06/23/13 End: 01/31/28 Due: 01/31/29

Risk of Psychopathology and Neurocognitive Impairment in Leukemia Survivors

Phase: N/A Priority: Normal
NCT ID: NCT01014195 Org: User:
Start: 01/31/10 End: 10/31/14 Due: 10/31/15